プライマリ細胞の市場規模、シェア、動向分析レポート：由来別、タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

プライマリ細胞市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のプライマリ細胞市場規模は2030年までに40億米ドルに達し、2024年から2030年までのCAGRは10.39%で成長すると予測されています。

同市場は、モノクローナル抗体の需要増加、がん研究の活発化、細胞株よりも1次ヒト細胞への嗜好の高まり、細胞ベースの研究に対する政府のイニシアチブの増加などにより成長が見込まれています。

がんや自己免疫疾患などの慢性疾患が世界的に急増していることから、モノクローナル抗体のような標的治療薬に対する需要が高まっています。これらのバイオ医薬品は、健康な細胞への影響を最小限に抑えながら、病気の細胞を選択的に標的にすることで効果的な治療アプローチを提供するため、採用が増加しています。モノクローナル抗体の生産には、多くの場合、生体や組織から直接採取した細胞であるプライマリ細胞が用いられます。プライマリ細胞は、その由来となった組織や生物の遺伝的・表現型的特徴を保持しているため、生物学的プロセスの研究や抗体産生のための、より確かなモデルとなります。

さらに、ヒトプライマリ細胞は細胞治療分野の研究開発において重要な役割を果たしています。細胞療法は、損傷した組織や臓器を置き換えたり修復したりするために細胞を移植するもので、様々な疾患や状態に対する有望な治療選択肢を提供します。生きている組織から直接得られたヒト1次細胞は、不死化細胞株よりも生理学的により適切なモデルを提供し、細胞治療研究における貴重なツールとなります。ヒトプライマリ細胞におけるHLAタイプやCMVステータスを含むドナー間のばらつきは、個人差が治療結果に影響を及ぼす可能性が高いため、細胞治療における個別化医療アプローチにとって重要です。さらに、プライマリ細胞誘導を専門とするCRO（Contract Research Organizations）は、多様な組織ソースからのプライマリ細胞の分離・調製に関する幅広いサービスを研究者に提供しています。

プライマリ細胞市場レポートハイライト

• ヒトプライマリ細胞は、in vivoにおける細胞の生理的状態に近いため、不死化細胞株よりも生物学的に関連性の高いデータを提供することができます。
• 2023年には、造血細胞タイプが最大の市場シェアを占めました。一方、骨格・筋肉細胞セグメントは、2024年から2030年にかけて12.51%のCAGRで最も高い成長が見込まれています。
• 2023年には、がん研究が用途別セグメントを支配し、37.74%の最大市場シェアを占めました。さらに、再生医療セグメントは予測期間中に最も高いCAGRで成長すると予測されています。
• 最終用途別では、製薬・バイオテクノロジー企業が2023年の収益で最大の市場シェアを占めました。
• 北米は、がん研究、細胞治療、個別化医療、再生医療分野への投資の増加により、36.11%の収益シェアでプライマリ細胞市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 プライマリ細胞市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し。
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 業界分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 プライマリ細胞市場：由来の推定・動向分析

• セグメントダッシュボード
• 世界のプライマリ細胞市場：由来変動分析
• 世界のプライマリ細胞市場規模と動向分析、由来別、2018～2030年
• ヒトプライマリ細胞
• 動物プライマリ細胞

第5章 プライマリ細胞市場：タイプの推定・動向分析

• セグメントダッシュボード
• 世界のプライマリ細胞市場：タイプ変動分析
• 世界のプライマリ細胞市場規模と動向分析、タイプ別、2018～2030年
• 造血細胞
• 皮膚細胞
• 肝細胞
• 消化管細胞
• 肺細胞
• 腎細胞
• 心臓細胞
• 骨格細胞と筋細胞
• その他のプライマリ細胞

第6章 プライマリ細胞市場：用途の推定・動向分析

• セグメントダッシュボード
• 世界のプライマリ細胞市場：用途変動分析
• 世界のプライマリ細胞市場規模と動向分析、用途別、2018～2030年
• 医薬品の発見と開発
• 再生医療
• がん調査
• その他

第7章 プライマリ細胞市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 世界のプライマリ細胞市場：最終用途変動分析
• 世界のプライマリ細胞市場規模と動向分析、最終用途別、2018～2030年
• 製薬・バイオテクノロジー企業
• 学術研究機関
• 委託研究機関

第8章 プライマリ細胞市場： 由来、タイプ、用途、最終用途別の地域推定・動向分析。

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2023年
• 企業プロファイル/上場企業
  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza
  • Cell Biologics, Inc.
  • PromoCell
  • ZenBio
  • STEMCELL Technologies
  • AllCells
  • American Type Culture Collection
  • Axol Biosciences Ltd.

List of Tables

• Table 1 List of abbreviation
• Table 2 Global primary cells market, by region, 2018 - 2030 (USD Million)
• Table 3 Global primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 4 Global primary cells market, by type, 2018 - 2030 (USD Million)
• Table 5 Global primary cells market, by application, 2018 - 2030 (USD Million)
• Table 6 Global primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 7 North America primary cells market, by country, 2018 - 2030 (USD Million)
• Table 8 North America primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 9 North America primary cells market, by type, 2018 - 2030 (USD Million)
• Table 10 North America primary cells market, by application, 2018 - 2030 (USD Million)
• Table 11 North America primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 12 U.S. primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 13 U.S. primary cells market, by type, 2018 - 2030 (USD Million)
• Table 14 U.S. primary cells market, by application, 2018 - 2030 (USD Million)
• Table 15 U.S. primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 16 Canada primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 17 Canada primary cells market, by type, 2018 - 2030 (USD Million)
• Table 18 Canada primary cells market, by application, 2018 - 2030 (USD Million)
• Table 19 Canada primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Mexico primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 21 Mexico primary cells market, by type, 2018 - 2030 (USD Million)
• Table 22 Mexico primary cells market, by application, 2018 - 2030 (USD Million)
• Table 23 Mexico primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 24 Europe primary cells market, by country, 2018 - 2030 (USD Million)
• Table 25 Europe primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 26 Europe primary cells market, by type, 2018 - 2030 (USD Million)
• Table 27 Europe primary cells market, by application, 2018 - 2030 (USD Million)
• Table 28 Europe primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 29 Germany primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 30 Germany primary cells market, by type, 2018 - 2030 (USD Million)
• Table 31 Germany primary cells market, by application, 2018 - 2030 (USD Million)
• Table 32 Germany primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 33 UK primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 34 UK primary cells market, by type, 2018 - 2030 (USD Million)
• Table 35 UK primary cells market, by application, 2018 - 2030 (USD Million)
• Table 36 UK primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 37 France primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 38 France primary cells market, by type, 2018 - 2030 (USD Million)
• Table 39 France primary cells market, by application, 2018 - 2030 (USD Million)
• Table 40 France primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 41 Italy primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 42 Italy primary cells market, by type, 2018 - 2030 (USD Million)
• Table 43 Italy primary cells market, by application, 2018 - 2030 (USD Million)
• Table 44 Italy primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 45 UK primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 46 Spain primary cells market, by type, 2018 - 2030 (USD Million)
• Table 47 Spain primary cells market, by application, 2018 - 2030 (USD Million)
• Table 48 Spain primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 49 Denmark primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 50 Denmark primary cells market, by type, 2018 - 2030 (USD Million)
• Table 51 Denmark primary cells market, by application, 2018 - 2030 (USD Million)
• Table 52 Denmark primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 53 Sweden primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 54 Sweden primary cells market, by type, 2018 - 2030 (USD Million)
• Table 55 Sweden primary cells market, by application, 2018 - 2030 (USD Million)
• Table 56 Sweden primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 57 Norway primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 58 Norway primary cells market, by type, 2018 - 2030 (USD Million)
• Table 59 Norway primary cells market, by application, 2018 - 2030 (USD Million)
• Table 60 Norway primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific primary cells market, by country, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific primary cells market, by type, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific primary cells market, by application, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 66 China primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 67 China primary cells market, by type, 2018 - 2030 (USD Million)
• Table 68 China primary cells market, by application, 2018 - 2030 (USD Million)
• Table 69 China primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 70 Japan primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 71 Japan primary cells market, by type, 2018 - 2030 (USD Million)
• Table 72 Japan primary cells market, by application, 2018 - 2030 (USD Million)
• Table 73 Japan primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 74 India primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 75 India primary cells market, by type, 2018 - 2030 (USD Million)
• Table 76 India primary cells market, by application, 2018 - 2030 (USD Million)
• Table 77 India primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 78 South Korea primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 79 South Korea primary cells market, by type, 2018 - 2030 (USD Million)
• Table 80 South Korea primary cells market, by application, 2018 - 2030 (USD Million)
• Table 81 South Korea primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 82 Australia primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 83 Australia primary cells market, by type, 2018 - 2030 (USD Million)
• Table 84 Australia primary cells market, by application, 2018 - 2030 (USD Million)
• Table 85 Australia primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 86 Thailand primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 87 Thailand primary cells market, by type, 2018 - 2030 (USD Million)
• Table 88 Thailand primary cells market, by application, 2018 - 2030 (USD Million)
• Table 89 Thailand primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 90 Latin America primary cells market, by country, 2018 - 2030 (USD Million)
• Table 91 Latin America primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 92 Latin America primary cells market, by type, 2018 - 2030 (USD Million)
• Table 93 Latin America primary cells market, by application, 2018 - 2030 (USD Million)
• Table 94 Latin America primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 95 Brazil primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 96 Brazil primary cells market, by type, 2018 - 2030 (USD Million)
• Table 97 Brazil primary cells market, by application, 2018 - 2030 (USD Million)
• Table 98 Brazil primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 99 Argentina primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 100 Argentina primary cells market, by type, 2018 - 2030 (USD Million)
• Table 101 Argentina primary cells market, by application, 2018 - 2030 (USD Million)
• Table 102 Argentina primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 103 MEA primary cells market, by country, 2018 - 2030 (USD Million)
• Table 104 MEA primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 105 MEA primary cells market, by type, 2018 - 2030 (USD Million)
• Table 106 MEA primary cells market, by application, 2018 - 2030 (USD Million)
• Table 107 MEA primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 108 South Africa primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 109 South Africa primary cells market, by type, 2018 - 2030 (USD Million)
• Table 110 South Africa primary cells market, by application, 2018 - 2030 (USD Million)
• Table 111 South Africa primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia primary cells market, by type, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia primary cells market, by application, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 116 UAE primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 117 UAE primary cells market, by type, 2018 - 2030 (USD Million)
• Table 118 UAE primary cells market, by application, 2018 - 2030 (USD Million)
• Table 119 UAE primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 120 Kuwait primary cells market, by origin, 2018 - 2030 (USD Million)
• Table 121 Kuwait primary cells market, by type, 2018 - 2030 (USD Million)
• Table 122 Kuwait primary cells market, by application, 2018 - 2030 (USD Million)
• Table 123 Kuwait primary cells market, by end-use, 2018 - 2030 (USD Million)
• Table 124 Participant's overview
• Table 125 Financial performance
• Table 126 Key companies undergoing expansions
• Table 127 Key companies undergoing acquisitions
• Table 128 Key companies undergoing collaborations
• Table 129 Key companies launching new products/services
• Table 130 Key companies undertaking other strategies

List of Figures

• Fig. 1 Primary cells market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Parent market outlook
• Fig. 13 Related/ancillary market outlook
• Fig. 14 Primary cells market driver analysis
• Fig. 15 Primary cells market restraint analysis
• Fig. 16 Primary cells market: Porter's analysis
• Fig. 17 Primary cells market: Origin outlook key takeaways
• Fig. 18 Primary cells market: Origin movement analysis
• Fig. 19 Human primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Animal primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Primary cells market: Type outlook key takeaways
• Fig. 22 Primary cells market: Type movement analysis
• Fig. 23 Hematopoietic Cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Skin cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Hepatocytes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Gastrointestinal cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Lung cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Renal cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Heart cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Skeletal and muscle cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Other primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Primary cells market: Application outlook key takeaways
• Fig. 33 Primary cells market: Application movement analysis
• Fig. 34 Drug discovery and development market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Regenerative medicine market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Primary cells market: End-use outlook key takeaways
• Fig. 39 Primary cells market: End-use movement analysis
• Fig. 40 Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Academic and research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Regional marketplace outlook, 2023 & 2030 (USD Million)
• Fig. 44 Regional marketplace: Key takeaways
• Fig. 45 North America primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Key country dynamics
• Fig. 47 U.S. primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Key country dynamics
• Fig. 49 Canada primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 Mexico primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Key country dynamics
• Fig. 53 Europe primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Key country dynamics
• Fig. 55 UK primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 Germany primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 France primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Spain primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Key country dynamics
• Fig. 63 Italy primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Denmark primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 Sweden primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 Norway primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Key country dynamics
• Fig. 71 Asia Pacific primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Key country dynamics
• Fig. 73 Japan primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 China primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Key country dynamics
• Fig. 77 India primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 Australia primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 Thailand primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 South Korea primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Key country dynamics
• Fig. 85 Latin America primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 Key country dynamics
• Fig. 87 Brazil primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Key country dynamics
• Fig. 89 Argentina primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 MEA primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 South Africa primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Key country dynamics
• Fig. 95 Saudi Arabia primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Key country dynamics
• Fig. 97 UAE primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 98 Key country dynamics
• Fig. 99 Kuwait primary cells market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 100 Key country dynamics
• Fig. 101 Market participant categorization
• Fig. 102 Global primary cells market position analysis, 2023
• Fig. 103 Strategic framework

Primary Cells Market Growth & Trends:

The global primary cells market size is anticipated to reach USD 4.00 billion by 2030, growing at a CAGR of 10.39% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to grow due to the increased demand for monoclonal antibodies, rising cancer research, growing preference for primary human cells over cell lines, and increasing government initiatives for cell-based research.

The surge in chronic diseases globally, such as cancer and autoimmune disorders, has led to a growing demand for targeted therapies like monoclonal antibodies. The adoption of these biopharmaceuticals is on the rise as they offer an effective treatment approach by selectively targeting diseased cells while minimizing the impact on healthy ones. The production of monoclonal antibodies often involves the use of primary cells, which are cells taken directly from living organisms or tissues. Primary cells retain the genetic and phenotypic characteristics of the original tissue or organism from which they were derived, making them more authentic models for studying biological processes and producing antibodies.

Moreover, human primary cells play a crucial role in research and development in the field of cell therapy. Cell therapy involves the transplantation of cells to replace or repair damaged tissues and organs, offering promising treatment options for various diseases and conditions. Human primary cells, derived directly from living tissue, provide a more physiologically relevant model than the immortalized cell lines, making them valuable tools in cell therapy research. Donor-to-donor variability, including HLA type and CMV status, in human primary cells is important for personalized medicine approaches in cell therapy as individual differences are likely to impact treatment outcomes. Furthermore, Contract Research Organizations (CROs) specializing in primary cell derivation provide researchers access to a wide range of services related to isolating and preparing primary cells from diverse tissue sources.

Primary Cells Market Report Highlights:

• Human primary cells dominated the origin segment in 2023, owing to their importance in research as they closely resemble the physiological state of cells in vivo, thereby providing more biologically relevant data than immortalized cell lines.
• The hematopoietic cells type segment held the largest market share in 2023. On the other hand, skeletal and muscle cells segment is expected to grow at the highest CAGR of 12.51% from 2024 to 2030.
• In 2023, cancer research dominated the application segment and held the largest market share of 37.74%. Furthermore, the regenerative medicine segment is expected to grow at the highest CAGR over the forecast period.
• Based on end-use, the pharmaceuticals & biotechnology companies segment held the largest market share in terms of revenue in 2023.
• North America dominated the market for primary cells with a revenue share of 36.11% owing to the growing investments in the field of cancer research, cell therapies, and personalized and regenerative medicine.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Origin
  • 1.2.2. Type
  • 1.2.3. Application
  • 1.2.4. End-use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Primary Cells Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing demand for monoclonal antibodies
    • 3.2.1.2. Increasing cancer research
    • 3.2.1.3. Increasing government initiatives for cell-based research
    • 3.2.1.4. Growing advantages of primary human cells over cell lines
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Ethical and regulatory concerns related to the use of primary cells
• 3.3. Industry Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Primary Cells Market: Origin Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Primary Cells Market Origin Movement Analysis
• 4.3. Global Primary Cells Market Size & Trend Analysis, by Origin, 2018 to 2030 (USD Million)
• 4.4. Human Primary Cells
  • 4.4.1. Human primary cells market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Animal Primary Cells
  • 4.5.1. Animal primary cells market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Primary Cells Market: Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Primary Cells Market Type Movement Analysis
• 5.3. Global Primary Cells Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. Hematopoietic Cells
  • 5.4.1. Hematopoietic cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Skin Cells
  • 5.5.1. Skin cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Hepatocytes
  • 5.6.1. Hepatocytes market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Gastrointestinal Cells
  • 5.7.1. Gastrointestinal cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Lung Cells
  • 5.8.1. Lung cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Renal Cells
  • 5.9.1. Renal cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.10. Heart Cells
  • 5.10.1. Heart cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.11. Skeletal and Muscle Cells
  • 5.11.1. Skeletal and muscle cells market estimates and forecasts 2018 to 2030 (USD Million)
• 5.12. Other Primary Cells
  • 5.12.1. Other primary cells market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Primary Cells Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Primary Cells Market Application Movement Analysis
• 6.3. Global Primary Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Drug Discovery and Development
  • 6.4.1. Drug discovery and development market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Regenerative Medicine
  • 6.5.1. Regenerative medicine market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Cancer Research
  • 6.6.1. Cancer research market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Primary Cells Market: End-use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Primary Cells Market End-use Movement Analysis
• 7.3. Global Primary Cells Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 7.4. Pharmaceuticals & Biotechnology companies
  • 7.4.1. Pharmaceuticals & Biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Academic and research institutes
  • 7.5.1. Academic and research institutes market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Contract research organizations
  • 7.6.1. Contract research organizations market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Primary Cells Market: Regional Estimates & Trend Analysis By Origin, Type, Application, End-Use.

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.7. Norway
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Regulatory framework
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Regulatory framework
    • 8.5.8.3. Competitive scenario
    • 8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.9. Denmark
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Regulatory framework
    • 8.5.9.3. Competitive scenario
    • 8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Regulatory framework
    • 8.8.4.3. Competitive scenario
    • 8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Regulatory framework
    • 8.8.5.3. Competitive scenario
    • 8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2023
• 9.4. Company Profiles/Listing
  • 9.4.1. Thermo Fisher Scientific
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Merck KGaA
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Lonza
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Cell Biologics, Inc.
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. PromoCell
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. ZenBio
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. STEMCELL Technologies
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. AllCells
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. American Type Culture Collection
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Axol Biosciences Ltd.
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives